Invention Grant
- Patent Title: Fused imidazole derivative
- Patent Title (中): 熔融咪唑衍生物
-
Application No.: US11667282Application Date: 2005-11-07
-
Publication No.: US08030327B2Publication Date: 2011-10-04
- Inventor: Yoshiyuki Sato , Hideki Kurihara , Kaori Kamijo , Yu Onozaki , Toshiaki Tsujino , Tetsuya Sugimoto , Akiko Watanabe , Morihiro Mitsuya , Hideya Komatani
- Applicant: Yoshiyuki Sato , Hideki Kurihara , Kaori Kamijo , Yu Onozaki , Toshiaki Tsujino , Tetsuya Sugimoto , Akiko Watanabe , Morihiro Mitsuya , Hideya Komatani
- Applicant Address: JP Chiyoda-Ku
- Assignee: MDS K.K.
- Current Assignee: MDS K.K.
- Current Assignee Address: JP Chiyoda-Ku
- Agent Nicole M. Beeler; David A. Muthard
- Priority: JP2004-323438 20041108
- International Application: PCT/JP2005/020763 WO 20051107
- International Announcement: WO2006/049339 WO 20060511
- Main IPC: A01N43/42
- IPC: A01N43/42 ; A01N43/38 ; A01N43/06 ; A61K31/44 ; A61K31/40 ; A61K31/38 ; C07D513/02 ; C07D515/02 ; C07D333/02 ; C07D333/34 ; C07D333/22
Abstract:
The present invention relates to a compound represented by the Formula [I]: Wherein: the A ring is a 5-membered aromatic heterocyclic group containing at least one hetero atom selected from a nitrogen atom, and the like; A1 and A2, are each a nitrogen atom, and the like; X2, X3, X4, and X5 are all carbon atoms, or alternatively any one of X2, X3, X4, and X5 is a nitrogen atom and the rest are all carbon atoms; R1 is a hydrogen atom, or the like; R2, R3, R4, and R5, are each a hydrogen atom, or the like; R6 and R6′, are each a hydrogen atom, and the like; R7 is an aryl group and the like; and R8 is an amino group or a hydroxy group, or a pharmaceutically acceptable salt or ester thereof.
Public/Granted literature
- US20080103136A1 Novel Fused Imidazole Derivative Public/Granted day:2008-05-01
Information query
IPC分类:
